The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema

被引:0
作者
C. H. Lee
J. E. Belanger
Z. Kassam
M. Smieja
D. Higgins
G. Broukhanski
P. T. Kim
机构
[1] McMaster University,Department of Pathology and Molecular Medicine
[2] St Joseph’s Healthcare,Department of Medicine
[3] McMaster University,Division of Gastroenterology, Department of Medicine
[4] St Joseph’s Healthcare,Harvard School of Public Health
[5] McMaster University,Laboratory Medicine and Pathobiology
[6] Harvard University,Department of Mathematics and Statistics
[7] University of Toronto,undefined
[8] University of Guelph,undefined
[9] Statistical and Applied Mathematical Sciences Institute,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2014年 / 33卷
关键词
Clostridium Difficile Infection; Fecal Microbiota Transplantation; Oral Vancomycin; Recurrent Clostridium Difficile Infection; Retention Enema;
D O I
暂无
中图分类号
学科分类号
摘要
Clostridium difficile infection (CDI) is one of the most frequent causes of healthcare-associated infections, and its rates are also increasing in the community. The management of CDI has become a major challenge, given growing rates of recurrences and failures with standard antibiotic therapy. Mounting evidence suggests that fecal microbiota transplantation (FMT) may be effective; however, as there is a paucity of data with regard to repeat FMT for primary non-response to this treatment, this study examined the outcome of multiple FMTs for recurrent CDI. Case records were reviewed for 94 patients who underwent FMT via retention enema for recurrent or refractory CDI during the period 2008–2012. Demographic information, treatment data, and clinical resolution rates were examined for single FMT and cumulative resolution was assessed for multiple FMTs in the context of ongoing symptoms. The cumulative clinical resolution following four or more FMTs was 86 %. When antibiotic therapy was used between FMTs, the clinical resolution rate increased to 92 %. There were no reported adverse events and no patients who were cured with FMT had further episodes of CDI at 6–24 months follow-up. Multiple FMTs administered through enemas is an effective, safe, and simple therapy for the management of recurrent or refractory CDI.
引用
收藏
页码:1425 / 1428
页数:3
相关论文
共 40 条
  • [1] Kelly CP(2008)—more difficult than ever N Engl J Med 359 1932-1940
  • [2] LaMont JT(2005)A predominantly clonal multi-institutional outbreak of N Engl J Med 353 2442-2449
  • [3] Loo VG(2008)-associated diarrhea with high morbidity and mortality J Hosp Infect 70 15-20
  • [4] Poirier L(2012)Costs of nosocomial Clin Infect Dis 55 S88-S92
  • [5] Miller MA(2005)-associated diarrhoea Clin Infect Dis 40 1586-1590
  • [6] Vonberg RP(2013)Burden of N Engl J Med 368 407-415
  • [7] Reichardt C(2013) on the healthcare system Am J Gastroenterol 108 500-508
  • [8] Behnke M(2012)Relatively poor outcome after treatment of Arch Intern Med 172 191-193
  • [9] Schwab F(2010) colitis with metronidazole Infect Control Hosp Epidemiol 31 431-455
  • [10] Zindler S(2013)Duodenal infusion of donor feces for recurrent Anaerobe 19 22-26